Regeneron Pharmaceuticals, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

745,233

Value ($000)

575,223

Weight

0.1%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	575,223	0.1%	745,233	12/31/2025
2025 Q3	11/14/2025	418,426	0.1%	744,173	9/30/2025
2025 Q2	8/14/2025	451,732	0.1%	860,441	6/30/2025
2025 Q1	5/19/2025	596,389	0.2%	940,336	3/31/2025
2024 Q4	2/14/2025	699,554	0.2%	982,064	12/31/2024
2024 Q3	11/14/2024	793,804	0.2%	755,112	9/30/2024
2024 Q2	8/14/2024	890,939	0.3%	847,682	6/30/2024
2024 Q1	5/15/2024	658,886	0.2%	684,564	3/31/2024
2023 Q4	2/14/2024	585,276	0.2%	666,381	12/31/2023
2023 Q3	11/13/2023	572,276	0.3%	695,387	9/30/2023
2023 Q2	8/11/2023	547,383	0.3%	666,184	6/30/2023
2023 Q1	5/15/2023	547,383	0.3%	666,184	3/31/2023
2022 Q4	2/14/2023	438,201	0.2%	607,356	12/31/2022
2022 Q3	11/14/2022	414,007	0.2%	600,994	9/30/2022
2022 Q2	8/12/2022	356,775	0.2%	603,548	6/30/2022
2022 Q1	5/16/2022	402,404	0.2%	576,163	3/31/2022
2021 Q4	2/14/2022	383,912	0.1%	607,918	12/31/2021
2021 Q3	11/15/2021	317,242	0.1%	524,211	9/30/2021
2021 Q2	8/16/2021	320,165	0.1%	573,218	6/30/2021
2021 Q1	5/14/2021	292,564	0.1%	618,346	3/31/2021
2020 Q4	3/1/2021	310,853	0.1%	643,442	12/31/2020
2020 Q3	11/13/2020	331,501	0.2%	592,199	9/30/2020
2020 Q2	8/14/2020	313,108	0.2%	502,057	6/30/2020
2020 Q1	5/15/2020	163,133	0.1%	334,091	3/31/2020
2019 Q4	2/14/2020	124,378	0.1%	331,250	12/31/2019
2014 Q1	5/23/2014	330,021	0.4%	1,099,048	3/31/2014
2013 Q4	1/31/2014	279,422	0.3%	1,015,189	12/31/2013